However, certain studies have also reached the opposite conclusion, finding that the absence of RUNX1 expression in breast cancer is associated with activation of the TGF-β and WNT signaling pathways, and that a low RUNX1 expression level suggests a poor prognosis in breast cancer [97]. Here, TGFB1 is linked to breast carcinoma.